Latest Innovation News

4DMedical has won a crucial US Medicare reimbursement for its CT, VQ™ lung imaging software, paving the way for rapid adoption across American hospitals. This milestone follows FDA clearance and promises to transform lung diagnostics with safer, faster scans.

8common’s subsidiary Expense8 has renewed its contract with the NSW Department of Education for another two years, reinforcing its role as a key provider of travel and expense management software in government.

333D Limited has responded to ASX queries, clarifying that its Bitcoin Treasury Management Policy approval is not price sensitive, while disclosing a $370,500 Bitcoin acquisition funded partly by R&D tax incentives.

NRW Holdings has agreed to acquire Fredon Industries for up to $200 million, introducing a new strategic pillar and broadening its service capabilities in energy transition and infrastructure. The deal is expected to complete by September 30, 2025, with strong earnings visibility for FY26.

NRW Holdings has agreed to acquire Fredon Industries for up to $200 million, significantly broadening its electrical, mechanical, infrastructure, and technology services. The deal is expected to boost NRW’s earnings and open new growth avenues tied to energy transition and digital innovation.

Advanced Braking Technology (ABT) reported robust FY25 financial results marked by revenue growth and improved profitability, while advancing its strategic roadmap focused on mining safety innovations and global market expansion.

Carnegie Clean Energy is closing its Share Purchase Plan on 8 September, offering shareholders a discounted entry to fund key ocean energy projects. The capital raise aims to accelerate development in Europe, the US, and Australia.

IMEXHS Limited reported steady revenue growth and a strategic push to scale its SaaS medical imaging platform, while navigating margin challenges and regulatory risks in Colombia.

Scalare Partners has successfully closed a $3.09 million capital raise, combining a $3 million placement and a Share Purchase Plan, to fund its acquisition of Tank Stream Labs and expand its technology portfolio.

4DMedical has bolstered its financial footing with a $6 million R&D tax incentive and a $10 million strategic investment, while its XV LVAS® technology gains clinical validation for predicting serious COPD treatment complications.

Race Oncology has activated its first clinical trial site in Hong Kong for the Phase 1 study of RC220 combined with doxorubicin in advanced solid tumours, marking a significant step in accelerating patient enrolment and broadening clinical data.

Robotics innovator FBR Limited has closed its Share Purchase Plan, securing approximately $700,000 in applications and preparing to issue new shares by early September.